###begin article-title 0
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Identification and characterization of OGG1 mutations in patients with Alzheimer's disease
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 303 307 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 410 414 410 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 451 454 451 454 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">796</sub>
###xml 606 614 606 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 676 679 676 679 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">796</sub>
###xml 688 692 688 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 976 980 976 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 1104 1108 1104 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 219 227 <span type="species:ncbi:9606">patients</span>
###xml 378 386 <span type="species:ncbi:9606">patients</span>
###xml 962 970 <span type="species:ncbi:9606">patients</span>
###xml 1087 1095 <span type="species:ncbi:9606">patients</span>
###xml 1239 1247 <span type="species:ncbi:9606">patients</span>
Patients with Alzheimer's disease (AD) exhibit higher levels of 8-oxo-guanine (8-oxoG) DNA lesions in their brain, suggesting a reduced or defective 8-oxoG repair. To test this hypothesis, this study investigated 14 AD patients and 10 age-matched controls for mutations of the major 8-oxoG removal gene OGG1. Whereas no alterations were detected in any control samples, four AD patients exhibited mutations in OGG1, two carried a common single base (C796) deletion that alters the carboxyl terminal sequence of OGG1, and the other two had nucleotide alterations leading to single amino acid substitutions. In vitro biochemical assays revealed that the protein encoded by the C796-deleted OGG1 completely lost its 8-oxoG glycosylase activity, and that the two single residue-substituted OGG1 proteins showed a significant reduction in the glycosylase activity. These results were consistent with the fact that nuclear extracts derived from a limited number of AD patients with OGG1 mutations exhibited greatly reduced 8-oxoG glycosylase activity compared with age-matched controls and AD patients without OGG1 alterations. Our findings suggest that defects in OGG1 may be important in the pathogenesis of AD in a significant fraction of AD patients and provide new insight into the molecular basis for the disease.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 397 398 397 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 538 539 538 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 699 700 699 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 832 835 832 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3 B4 B5 B6">3&#8211;6</xref>
###xml 943 944 943 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
Alzheimer's disease (AD) is the most common form of adult dementia and is characterized by progressive cognitive deterioration, impairment of activities of daily living, and a variety of neuropsychiatric symptoms and behavioral disturbances. It is generally accepted that the production and accumulation of beta-amyloid peptide in the brain in AD are important in the pathogenesis of the disease (1). Increasing evidence supports that mutations in the beta-amyloid precursor protein and the presenilins lead to some early-onset AD cases (1). Although mutations can be induced by numerous endogenous and exogenous agents, oxidative stress has been thought to be the main source for DNA damage in AD (2). Indeed, previous studies have demonstrated that increased nuclear and mitochondrial DNA oxidation is present in the brain in AD (3-6), with 8-hydroxyguanine or its isomeric form 7,8-dihydro-8-oxoguanine (8-oxoG) being the major DNA lesion (7).
###end p 4
###begin p 5
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8 B9 B10">8&#8211;10</xref>
###xml 735 736 735 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 990 995 990 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11 B12 B13">11&#8211;13</xref>
###xml 1030 1034 1030 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 1112 1114 1112 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1115 1117 1115 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1226 1228 1226 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1324 1326 1324 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 957 962 <span type="species:ncbi:9606">human</span>
###xml 1012 1016 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
The 8-oxoG is highly mutagenic because adenine is preferentially incorporated opposite the oxidized base upon replication by DNA polymerases, yielding GC to TA transversions. To prevent 8-oxoG-induced mutagenesis, cells possess a mechanism called the GO system, which consists of MutY homolog (MYH), OGG1 (8-oxoG-DNA glycosylase I, the eukaryotic homolog of MutM), and MutT (8-10). The MutT protein is a phosphotase that specifically converts 8-oxo-dGTP in the nucleotide pool into 8-oxo-dGMP to keep the oxidized nucleotides from being incorporated into DNA during replication. Both MYH and OGG1 are 8-oxoG-specific DNA glycosylases. Unlike MutT, OGG1 and MYH are components of base excision repair and involved in processing 8-oxoG (9,10). Whereas, OGG1 actually removes 8-oxoG from damaged DNA, MYH excises the adenine residues incorporated by DNA polymerases opposite 8-oxoG. Mutations of OGG1 and MYH have been implicated in the development of certain human diseases including cancer (11-13). Gene knockout mice defective in OGG1 accumulate higher levels of 8-oxoG lesions compared with wild-type controls (14,15), and exhibit elevated spontaneous mutations, especially when exposed to higher levels of oxidative stress (16). These observations suggest that OGG1 acts as a major pathway responsible for 8-oxoG removal (17).
###end p 5
###begin p 6
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 223 227 223 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 107 115 <span type="species:ncbi:9606">patients</span>
###xml 262 270 <span type="species:ncbi:9606">patients</span>
To determine the impact of OGG1 in AD development, DNA and/or protein samples derived from the brain of AD patients and age-matched controls were analyzed for defects in OGG1 and OGG1 glycosylase activity. Mutations of the OGG1 gene were indeed identified in AD patients. Biochemical studies revealed that these mutations either completely inactivate or severely reduce the OGG1 DNA-glycosylase activity, suggesting that defects in OGG1 are associated with the development of AD.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
AD sample collection
###end title 8
###begin p 9
###xml 307 308 307 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 655 657 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 724 726 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 29 37 <span type="species:ncbi:9606">patients</span>
###xml 444 452 <span type="species:ncbi:9606">patients</span>
###xml 587 595 <span type="species:ncbi:9606">patients</span>
###xml 736 744 <span type="species:ncbi:9606">patients</span>
Brain specimens were from AD patients and normal control subjects who were longitudinally followed with annual detailed assessments in the University of Kentucky Alzheimer's Disease Center. The specimens were evaluated in a blinded manner in our study. These samples were collected as described previously (3). Briefly, 10-15 g specimens of frontal, temporal and parietal lobes and cerebellum were dissected en bloc at the time of autopsy from patients with AD and age-matched normal control subjects. The tissue was snap-frozen and stored at -70degreesC until used for analysis. All AD patients met standard clinical diagnostic criteria for probable AD (18) and accepted histopathological criteria for the diagnosis of AD (19). The AD patients were in the late stage of AD. Control subjects were individuals without a history of dementia, other neurological disorders or systemic disease affecting the brain. Neuropathological studies revealed no significant neuropathological alterations in the control subjects. The mean age for the control cases was 92.3 and 72.0 years for the AD cases. The average postmortem interval was 2.90 +/- 0.31 h for AD and 3.36 +/- 0.47 h for control subjects.
###end p 9
###begin title 10
OGG1 activity assay
###end title 10
###begin p 11
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 505 507 505 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 807 809 806 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
Preparation of nuclear extracts from brain specimens was performed as described previously (20). Because of potential variations in water content in tissues collected from various individuals (both AD and control subjects), data were normalized to protein content for each isolated nuclear fraction, rather than using the same amount of starting materials for extract preparations. The OGG1 glycosylase activity was measured essentially as described (21) using an oligonucleotide duplex consisting of the 32P-labeled 5'-ATTGCCATTCTCGATA[8-oxoG]GATCCGGTCAAACCTAGAC-3' and the cold complementary strand 5' GTCTAGGTTTGACCGGATCCTATCGAGAATGGCAAT-3'. Briefly, incision reactions (20 mul) contained 50 mM sodium phosphate buffer (pH 6.8), 2 mM EDTA, 2 mM DTT, 80 mM KCl, 0.1 mg/ml of BSA, 10% glycerol, 50 fmol of 32P-labeled duplex and 40 mug of nuclear extracts or indicated amount of purified wild-type or mutant OGG1 protein. After incubation at 37degreesC for 1 h, the reactions were terminated by adding an equal volume of a stop solution (95% formamide, 20 mM EDTA, 0.05% bromophenol blue and 0.05% xylem cyanol). The reaction products were resolved on a 15% denaturing gel and visualized by a phosphorimager.
###end p 11
###begin title 12
Site-directed mutagenesis, overexpression and purification of OGG1
###end title 12
###begin p 13
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 310 318 310 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 368 371 368 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">796</sub>
###xml 384 388 384 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 523 525 523 525 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</bold>
###xml 561 563 561 563 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC</bold>
###xml 828 832 828 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 869 877 869 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1048 1051 1048 1051 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">796</sub>
###xml 1366 1370 1366 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 1554 1557 1554 1557 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">796</sub>
###xml 1566 1570 1566 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 1593 1596 1593 1596 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">796</sub>
###xml 1668 1672 1668 1672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 1441 1448 <span type="species:ncbi:9606">patient</span>
The His-tagged human OGG1 expression vector (pET28d) was kindly provided by Drs Sankar Mitra and Tapas K. Hazra, University of Texas Medical Branch at Galveston. Construction of the OGG1 mutants associated with AD was performed using an overlap-extension PCR technology as described (22), which is depicted in Figure 1, showing the strategy for the generation of the C796-deletion of OGG1. Two sets of PCR primers were used: forward primer 1 (RP1), 5'-GGGGAATTGTGAGCGGATAAC-3', and reverse primer 1 (RP1), 5'-ATATGGACATCCACGGCACAGCCTGGGGCTT-3'; FP2, 5'-AGGCTGTGCCGTGGATGTCCATATGT-3' and RP2, 5'-GGTGGTGGTGGTGCTCGAG-3', where the bold types represent the mutation site. PCR products from the two sets of reactions were mixed, denatured and reannealed. Because these PCR products overlapped at their 3' ends, a full-length mutant OGG1 was generated via 3' end extension (Figure 1). The full-length mutant gene was amplified using primers FP1 and RP2, digested with XhoI and XbaI, and cloned into the XhoI/XbaI-digested pET28d expression vector. The C796 deletion results in a frame-shift mutation that allows the mutated gene to encode a protein 59 amino acids longer than the wild-type OGG1 (see below for details). Thus, a pair of primers (5'-ACTGTCACTAGTCTCACCAG-3' and 5'-ATACTCGAGTCAATATCCCCCACCCCATCTTGTTG-3') were used to amplify part of the exon 7 sequence of OGG1 and its 3' untranslated region (3'-UTR) from genomic DNA derived from patient AD2. After digestion with BspMI and XhoI, the PCR product was cloned into pET28d plasmid containing the C796-deleted OGG1. The presence of the C796 deletion and the extended 3'UTR was confirmed by DNA sequencing. Other OGG1 mutants identified in AD were similarly constructed.
###end p 13
###begin p 14
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 61 77 61 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 173 178 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 61 89 <span type="species:ncbi:511693">Escherichia coli strain BL21</span>
The wild-type and mutant OGG1 plasmids were transformed into Escherichia coli strain BL21 DE3 for expression and the recombinant proteins were purified as described by Hill et al. (23). The purified proteins (>98% purity, as judged by Coomassie Brilliant Blue R-250 staining on an SDS-PAGE gel) were aliquoted and stored at -80degreesC for use.
###end p 14
###begin title 15
Single-strand conformational polymorphism and DNA sequencing analyses
###end title 15
###begin p 16
###xml 96 101 96 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 200 204 200 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 319 323 319 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 352 357 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 50 58 <span type="species:ncbi:9606">patients</span>
Nuclear DNA was isolated from brain regions of AD patients and controls as described by Gabbita et al. (3). PCR-based single-strand conformation polymorphism (SSCP) was used to determine mutations in OGG1. PCR primers (Supplementary Data, Table S1) were used to amplify all seven exons and flanking splice sites of the OGG1 gene as described by Murata et al. (24). Variant and wild-type PCR products were excised and eluted from SSCP gels, and then reamplified. The resulting PCR products were sequenced using T7 Sequenase, version 2.0 DNA sequencing kit (USB Corp., Cleveland, OH, USA).
###end p 16
###begin title 17
Statistical analysis
###end title 17
###begin p 18
###xml 42 43 42 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 61 62 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 96 97 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 160 168 160 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 196 203 196 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
Statistical analyses were performed using t-test function in R package. Specifically, one-sided t-test was used to compare 8-oxoG glycosylase activity shown in Figure 2 and 8-oxoG lesion level in Table 1.
###end p 18
###begin title 19
RESULTS
###end title 19
###begin title 20
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Reduced 8-oxoG DNA glycosylase activity in AD patients
###end title 20
###begin p 21
###xml 289 297 289 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 945 946 945 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 43 51 <span type="species:ncbi:9606">patients</span>
###xml 111 119 <span type="species:ncbi:9606">patients</span>
###xml 178 186 <span type="species:ncbi:9606">patients</span>
###xml 503 511 <span type="species:ncbi:9606">patients</span>
###xml 751 759 <span type="species:ncbi:9606">patients</span>
###xml 870 877 <span type="species:ncbi:9606">patient</span>
###xml 1038 1046 <span type="species:ncbi:9606">patients</span>
The abundance of 8-oxoG in the brain of AD patients prompted us to determine 8-oxoG glycosylase activity in AD patients. Nuclear extracts obtained from the brain specimens of AD patients were examined for their ability to cleave a duplex DNA containing a single 8-oxoG lesion. As shown in Figure 2, the nuclear extracts derived from all three age-matched controls (C1, C2 and C3) exhibited high levels (8% or more) of 8-oxoG glycosylase activity, whereas extracts from two (AD2 and AD3) of the three AD patients tested had only about one-half of the glycosylase activity observed in the control samples. These results were repeatable. Statistical analysis revealed that the observed difference in glycosylase activity between extracts derived from AD patients with lower 8-oxoG glycosylase activity (AD2 and AD3) and those isolated from control subjects (C1-3) or an AD patient with normal glycosylase activity (i.e. AD1) is highly significant (P = 0.00298). These observations suggest that reduced repair of 8-oxoG is associated with AD patients.
###end p 21
###begin title 22
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 21 29 <span type="species:ncbi:9606">patients</span>
OGG1 mutations in AD patients
###end title 22
###begin p 23
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 299 303 299 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 517 521 517 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 641 649 641 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 728 732 728 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 979 987 979 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1049 1053 1049 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 133 141 <span type="species:ncbi:9606">patients</span>
###xml 340 348 <span type="species:ncbi:9606">patients</span>
###xml 569 577 <span type="species:ncbi:9606">patients</span>
###xml 814 821 <span type="species:ncbi:9606">patient</span>
###xml 922 930 <span type="species:ncbi:9606">patients</span>
###xml 1063 1071 <span type="species:ncbi:9606">patients</span>
Because the major DNA glycosylase for removal of 8-oxoG is OGG1 (17), we reasoned that the reduced 8-oxoG glycosylase activity in AD patients could be due to a reduction in OGG1 activity. PCR primers (Supplementary Data, Table 1) were therefore designed to amplify all seven individual exons of the OGG1 gene from the brain specimens of AD patients and age-matched controls. The resulting PCR products were analyzed by SSCP as described (24). Whereas, no abnormal SSCP products were detected in exons 1-4, 6 and 7 of OGG1 in all samples tested (data not shown), two AD patients appeared to display aberrant SSCP bands in exon 5. As shown in Figure 3A, two specific products (bands 1 and 4), presumably the normal alleles of the OGG1 exon 5, were seen in the age-matched controls (data for C1 and C2 not shown) and patient AD1 but both normal and additional alleles (bands 2 and 3) were detected in AD2 and AD3, the two AD patients exhibiting reduced 8-oxoG glycosylase activity (Figure 2). These results seem to suggest a heterozygous alteration of OGG1 in these patients.
###end p 23
###begin p 24
###xml 126 134 126 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 261 265 261 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 321 329 321 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 422 426 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 445 448 445 448 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">796</sub>
###xml 451 454 451 454 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">797</sub>
###xml 459 462 459 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">798</sub>
###xml 560 563 560 563 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">796</sub>
###xml 632 640 632 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
To determine if the abnormal SSCP products of exon 5 in AD2 and AD3 were associated with mutation(s), SSCP bands 1-4 shown in Figure 3A were eluted from the gel, reamplified and sequenced. As expected, bands 1 and 4 from all samples indeed showed the wild-type OGG1 sequence, and examples of these sequences are shown in Figure 3B (see two gels on the left side for AD1 and C3). However, bands 2 and 3 exhibited a mutated OGG1 sequence as a C (C796, C797 or C798) was deleted from nucleotide positions 796-798. For simplicity, the mutation was referred to as C796-deleted. Interestingly, both AD2 and AD3 carried the same deletion (Figure 3B, two gels on the right side). The status of the heterozygous mutation in AD2 and AD3 was further confirmed by cloning the PCR products of exon 5 into a T-A cloning vector (Invitrogen, Carlsbad, CA, USA), followed by DNA sequencing. The results revealed an approximate 1:1 ratio of wild-type and mutant clones (data not shown).
###end p 24
###begin p 25
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 120 124 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 262 265 262 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">157</sub>
###xml 318 321 316 319 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">863</sub>
###xml 340 344 336 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 346 354 342 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 415 417 409 411 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">53</sub>
###xml 420 422 414 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">53</sub>
###xml 479 482 471 474 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">288</sub>
###xml 485 488 477 480 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">288</sub>
###xml 611 619 603 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 789 793 781 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 172 180 <span type="species:ncbi:9606">patients</span>
###xml 241 248 <span type="species:ncbi:9606">patient</span>
###xml 250 253 <span type="species:ncbi:9606">AD4</span>
###xml 293 300 <span type="species:ncbi:9606">patient</span>
###xml 302 305 <span type="species:ncbi:9606">AD5</span>
###xml 743 751 <span type="species:ncbi:9606">patients</span>
The association of a defective OGG1 in AD2 and AD3 prompted us to investigate 11 additional AD samples for mutations in OGG1. Abnormal SSCP products were identified in two patients (data not shown). DNA sequencing analysis revealed that one patient (AD4) had a G157-->A transition and another patient (AD5) carried a C863-->T transition in OGG1 (Figure 3C). The G-->A substitution changes amino acid residue alanine53 (A53) to threonine and the C-->T substitution changes alanine288 (A288) to valine. However, no nucleotide alterations were identified in any of the seven additional age-matched controls (C4 in Figure 3C, data for C5-C10 not shown). Taken together, our results suggest that a substantial fraction (28.6% or 4 out of 14) of AD patients are associated with mutations in the OGG1 gene.
###end p 25
###begin title 26
###xml 5 8 5 8 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">796</sub>
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
The C796-deleted OGG1 gene encodes a proteins lacking 8-oxoG glycosylase activity
###end title 26
###begin p 27
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 206 210 206 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 249 257 249 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 275 278 275 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">796</sub>
###xml 316 320 316 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 496 504 496 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 680 688 680 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
Given a single nucleotide deletion in the OGG1 gene, AD2 and AD3 were expected to express an altered OGG1 protein that possesses a carboxyl terminal different from that of the wild-type OGG1. The wild-type OGG1 gene encodes 345 amino acid residues (Figure 4A). However, the C796 deletion altered the coding frame of OGG1 at the mutation site. As a result, the translation does not terminate at codon 346, instead, it terminates 59 amino acid residues downstream of the previous termination site (Figure 4B). Thus, not only does the mutated protein contain different amino acid residues from the wild-type OGG1 following the mutation site, but also is 59-residue bigger than OGG1 (Figure 4B). The mutant protein was therefore referred to as OGG1-59aa.
###end p 27
###begin p 28
###xml 240 248 240 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 532 540 532 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 844 852 <span type="species:ncbi:9606">patients</span>
###xml 937 945 <span type="species:ncbi:9606">patients</span>
To determine if the mutated OGG1 retains 8-oxoG glycosylase activity, site-directed mutagenesis was performed to generate the OGG1-59aa as described in Materials and Methods section. Both the wild type and OGG1-59aa proteins were purified (Figure 5A) and assayed for the 8-oxoG glycosylase activity. Whereas, the wild-type OGG1 (W) was very active in cleaving the 8-oxoG-containing duplex, little such activity was detected in reactions with OGG1-59aa (M), regardless of the reaction incubation time and the amount of protein used (Figure 5B and C). Mixing experiments using various ratios of wild-type OGG1 versus OGG1-59aa indicated that the mutant protein had no negative inference on the wild-type OGG1 activity (data not shown), ruling out a dominant negative role for OGG1-59aa. These results indicate that a defective OGG1 is present in patients AD2 and AD3, which may account for the reduced 8-oxoG glycosylase activity in these patients.
###end p 28
###begin title 29
OGG1 with A53T or A288V substitution possesses a reduced 8-oxoG glycosylase activity
###end title 29
###begin p 30
###xml 180 188 180 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 233 241 233 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 482 490 482 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 607 615 607 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 681 682 681 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 682 683 682 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 724 732 724 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 910 918 <span type="species:ncbi:9606">patients</span>
###xml 919 922 <span type="species:ncbi:9606">AD4</span>
###xml 927 930 <span type="species:ncbi:9606">AD5</span>
###xml 1088 1096 <span type="species:ncbi:9606">patients</span>
To determine the impact of A53T or A288V substitution on OGG1 glycosylase activity, genes encoding OGG1(A53T) and OGG1(A288V) were created using a similar strategy as described in Figure 1, and the mutant proteins were purified (see Figure 5A) and examined for 8-oxoG glycosylase activity. Unlike OGG1-59aa, which is completely defective in 8-oxoG glycosylase activity, both OGG1(A53T) and OGG1(A288V) proteins were capable of cleaving the 8-oxoG-containing oligonucleotide duplex (Figure 6A and B). However, the glycosylase activity of both altered proteins was only 50-60% of the wild-type OGG1 activity (Figure 6C). Further analysis revealed that both mutant proteins possess a Km higher than that of the wild-type OGG1 (Figure 6D), indicating that the reduction in glycosylase activity for both mutant proteins is due to the reduction in enzyme's affinity to the DNA substrate. Although protein samples of patients AD4 and AD5 were not available for biochemical assays, our results strongly suggest that reduced 8-oxoG glycosylase activity was likely present in the brain of these AD patients.
###end p 30
###begin title 31
DISCUSSION
###end title 31
###begin p 32
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 420 424 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 230 238 <span type="species:ncbi:9606">patients</span>
###xml 340 348 <span type="species:ncbi:9606">patients</span>
###xml 484 492 <span type="species:ncbi:9606">patients</span>
Patients with AD have been shown to exhibit a much higher level of 8-oxoG DNA lesions in brain than age-matched normal control subjects (7). The increased level of 8-oxoG lesions in AD is likely due to reduced DNA repair in these patients. We provide here both the genetic and biochemical evidence that a significant fraction (28.6%) of AD patients examined in this study exhibited mutations in the 8-oxoG removing gene OGG1 and that OGG1 proteins with the mutations identified in AD patients have either no or greatly reduced 8-oxoG glycosylase activity.
###end p 32
###begin p 33
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 88 91 88 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">796</sub>
###xml 129 133 129 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 256 264 256 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 333 341 333 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 444 449 444 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 599 602 599 602 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">319</sub>
###xml 607 610 607 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">315</sub>
###xml 615 617 615 617 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">42</sub>
###xml 625 628 625 628 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">253</sub>
###xml 669 672 669 672 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">319</sub>
###xml 680 683 680 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">253</sub>
###xml 752 755 752 755 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">315</sub>
###xml 764 765 764 765 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 840 841 840 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 889 892 889 892 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">315</sub>
###xml 957 958 957 958 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 964 965 964 965 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 979 981 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1008 1011 1008 1011 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">268</sub>
###xml 1042 1045 1042 1045 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">249</sub>
###xml 1053 1056 1053 1056 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">270</sub>
###xml 1083 1086 1083 1086 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">249</sub>
###xml 1218 1220 1218 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1237 1240 1237 1240 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">796</sub>
###xml 1261 1265 1261 1265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 1393 1396 1393 1396 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">268</sub>
###xml 1401 1404 1401 1404 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">270</sub>
###xml 1409 1412 1409 1412 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">315</sub>
###xml 1420 1423 1420 1423 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">319</sub>
###xml 1461 1469 1461 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 33 41 <span type="species:ncbi:9606">patients</span>
###xml 417 422 <span type="species:ncbi:9606">human</span>
Interestingly, of four unrelated patients with OGG1 mutations, two (AD2 and AD3) had a C796 deletion mutation, which changes the OGG1 reading frame and leads to a different carboxyl terminal sequence, including an extra fragment of 59 amino acid residues (Figure 4). This mutation completely abolishes the OGG1 glycosylase activity (Figure 5). This result is consistent with previous crystal structure studies of the human OGG1 protein. Bruner et al. (25) demonstrated that the 8-oxoG lesion is extruded from the DNA helix and inserted into an extrahelical pocket composed of amino acid residues Phe319, Gln315, Gly42 and Cys253 of OGG1. In this active-site pocket, Phe319 and Cys253 sandwich the 8-oxoG lesion via interactions with the lesion; the Gln315 amide-NH2 and a water molecule tightly bound to the residue cooperate to recognize O6 of the oxoG; and the side-chain carbonyl of Gln315 and a second tightly bound water form hydrogen bonds with N1, NH2 and O6 of the oxoG (25). In addition, residue Asp268 is required to deprotonate Lys249 and His270 is needed to protonate Lys249, which acts to displace the oxoG base and to promote conjugate elimination of the 3' phosphodiester through Schiff base chemistry (25). However, the C796 deletion alters the OGG1 reading frame beginning at amino acid residue 267, leading to a protein no longer containing these important residues (i.e. Asp268, His270, Gln315 and Phe319) at the corresponding positions (see Figure 4A and B). Therefore, it is understandable that the OGG1-59aa has no 8-oxoG glycosylase activity.
###end p 33
###begin p 34
###xml 142 150 142 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 235 237 235 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">53</sub>
###xml 243 246 243 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">288</sub>
###xml 306 314 306 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 592 597 592 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26 B27 B28">26&#8211;28</xref>
###xml 601 603 601 603 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">53</sub>
###xml 699 702 690 693 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">288</sub>
###xml 836 838 815 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Two additional OGG1 mutations, A53T and A288V, were also identified in AD patients and both were found to reduce 8-oxoG glycosylase activity (Figure 6). The observed activities for these mutants appear to be justified by the roles of A53 and A288 in the OGG1 structure. OGG1 has two important domains (see Figure 4C): the OGG-N domain partially contributes to the 8-oxoG-binding pocket and the HhH-GPD domain (a helix-hairpin-helix structural element followed by a Gly/Pro-rich loop and a conserved aspartic acid) provides both the catalytic and DNA-binding functions of the DNA glycosylase (26-28). A53 is located in the region linking two beta sheets (beta B and beta C) in the OGG-N domain, and A288 is part of the polypeptide connecting two alpha-helices (alpha M and alpha N) involved in the catalytic activity of the glycosylase (25). Thus, both alanine residues are not in the active center of their corresponding domains. However, substitutions of these alanines with other residues may allow OGG1 to adapt a conformation that is slightly different from the wild-type conformation, leading to the observed reduced glycosylase activity. Whether or not these alterations represent polymorphism in the population remains to be defined. It is also important to determine if individuals with these types of OGG1 alterations are at higher risk to develop AD.
###end p 34
###begin p 35
###xml 190 198 190 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 458 462 458 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 509 517 509 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 810 814 810 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 825 829 825 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ogg1</italic>
###xml 829 832 829 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 932 934 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 935 937 935 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1007 1011 1007 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ogg1</italic>
###xml 1024 1026 1024 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1169 1171 1169 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
###xml 319 327 <span type="species:ncbi:9606">patients</span>
###xml 487 495 <span type="species:ncbi:9606">patients</span>
###xml 726 731 <span type="species:ncbi:9606">human</span>
###xml 792 796 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 833 837 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
It is interesting that, although a defective OGG1 was detected in the brain of patients AD2 and AD3, extracts derived from these tissues still contained partial 8-oxoG glycosylase activity (Figure 2). This phenomenon could be attributed to two possibilities. First, the alteration is a heterozygous mutation, thus, the patients possessed both wild-type and mutant OGG1. This possibility is supported by the fact that both wild-type and mutant alleles of the OGG1 exon 5 were detected in patients AD2 and AD3 (Figure 3A) and that the mutant OGG1 protein does not interfere with the wild-type protein on its glycosylase activity (data not shown). A second explanation is that there are multiple 8-oxoG glycosylase activities in human cells. Evidence for this assumption came from gene knockout mice defective in OGG1. Although Ogg1-/- mice manifest a steady-state level of 8-oxoG that is 3- to 10-fold higher than wild-type controls (14,15), there is slow but significant removal of 8-oxoG from proliferating Ogg1-null cells (29), indicating that alterative 8-oxoG repair pathways are present in mammalian cells. Indeed, such activities have been recently identified (17,30).
###end p 35
###begin p 36
###xml 191 194 191 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3 B4 B5 B6">3&#8211;6</xref>
###xml 476 479 476 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3 B4 B5 B6">3&#8211;6</xref>
###xml 537 540 537 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3 B4 B5 B6">3&#8211;6</xref>
###xml 593 597 593 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 655 659 655 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 710 714 710 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 728 735 728 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 742 743 742 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 864 865 864 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 103 111 <span type="species:ncbi:9606">patients</span>
###xml 441 449 <span type="species:ncbi:9606">patients</span>
###xml 567 575 <span type="species:ncbi:9606">patients</span>
###xml 1155 1163 <span type="species:ncbi:9606">patients</span>
###xml 1250 1258 <span type="species:ncbi:9606">patients</span>
###xml 1499 1507 <span type="species:ncbi:9606">patients</span>
The presence of multiple 8-oxoG glycosylase activities in mammalian cells may also explain why some AD patients who were previously shown to exhibit higher levels of 8-oxoG lesions in brain (3-6) seemed to be normal in OGG1 glycosylase activity, implying that deficiency in other 8-oxoG removal pathway(s) may also contribute to the high level of 8-oxoG in AD. Previous studies have shown significant differences in 8-oxoG levels between AD patients and age-matched controls (3-6). Interestingly, when 8-oxoG levels reported previously (3-6) were compared between AD patients with and without OGG1 mutations, it was found that the 8-oxoG level in AD with OGG1 alterations was higher than that in those without OGG1 alterations (Table 1). And t-test analysis revealed that the difference in 8-oxoG levels between these two groups is highly significant as judged by P = 0.025. These data indicate that whereas OGG1 is the major 8-oxoG removal enzyme, abnormality in other 8-oxoG removal pathway(s), and 8-oxoG tolerance (MYH) and cleansing (MutT homologs) pathways can also result in accumulation of the oxidized lesion. The identification of only 28.6% AD patients with OGG1 alterations also support the possibility that the remaining 71.4% of the AD patients could have mutations in MYH, MutT homologs and/or other 8-oxoG removal pathways. Although this hypothesis remains to be investigated, our results shown here indicate that defects in DNA repair, including the OGG1 pathway, are present in AD patients, providing a possible molecular basis for the development of AD.
###end p 36
###begin title 37
SUPPLEMENTARY DATA
###end title 37
###begin p 38
Supplementary Data are available at NAR online.
###end p 38
###begin title 39
ACKNOWLEDGEMENTS
###end title 39
###begin p 40
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 50 55 <span type="species:ncbi:9606">human</span>
We thank Drs Sankar Mitra and Tapas Hazra for the human OGG1 expression vector. This work was supported by a program project grant (P01 AG05119) and an Alzheimer's Disease Center Grant (1P30 AG0 28383) from the National Institute on Aging. X.P. was supported by a pre-doctoral fellowship from China Scholarship Council. G.M.L. is the James-Gardner Endowed Chair in Cancer Research, and W.R.M. is the Commonwealth Endowed Chair in Aging. Funding to pay the Open Access publication charges for this article was provided by the James F. Madeline and Edith D. Gardner Endowment to G.M.L
###end p 40
###begin p 41
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 41
###begin title 42
REFERENCES
###end title 42
###begin article-title 43
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics
###end article-title 43
###begin article-title 44
Oxidative stress hypothesis in Alzheimer's disease
###end article-title 44
###begin article-title 45
Increased nuclear DNA oxidation in the brain in Alzheimer's disease
###end article-title 45
###begin article-title 46
###xml 77 85 <span type="species:ncbi:9606">patients</span>
An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease
###end article-title 46
###begin article-title 47
Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment
###end article-title 47
###begin article-title 48
Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease
###end article-title 48
###begin article-title 49
Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid
###end article-title 49
###begin article-title 50
The GO system protects organisms from the mutagenic effect of the spontaneous lesion 8-hydroxyguanine (7,8-dihydro-8-oxoguanine)
###end article-title 50
###begin article-title 51
Multiple DNA glycosylases for repair of 8-oxoguanine and their potential in vivo functions
###end article-title 51
###begin article-title 52
###xml 23 39 23 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 23 39 <span type="species:ncbi:562">Escherichia coli</span>
Characterization of an Escherichia coli mutant MutY with a cysteine to alanine mutation at the iron-sulfur cluster domain
###end article-title 52
###begin article-title 53
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis
###end article-title 53
###begin article-title 54
Inherited variants of MYH associated with somatic G:C-->T : A mutations in colorectal tumors
###end article-title 54
###begin article-title 55
###xml 10 15 <span type="species:ncbi:9606">human</span>
Defective human MutY phosphorylation exists in colorectal cancer cell lines with wild-type MutY alleles
###end article-title 55
###begin article-title 56
###xml 44 48 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage
###end article-title 56
###begin article-title 57
###xml 74 78 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice
###end article-title 57
###begin article-title 58
###xml 50 54 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Cell proliferation in liver of Mmh/Ogg1-deficient mice enhances mutation frequency because of the presence of 8-hydroxyguanine in DNA
###end article-title 58
###begin article-title 59
###xml 128 133 <span type="species:ncbi:9606">Human</span>
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
###end article-title 59
###begin article-title 60
Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease
###end article-title 60
###begin article-title 61
Decreased base excision repair and increased helicase activity in Alzheimer's disease brain
###end article-title 61
###begin article-title 62
###xml 81 84 <span type="species:ncbi:10116">rat</span>
Age-associated increase in 8-oxo-deoxyguanosine glycosylase/AP lyase activity in rat mitochondria
###end article-title 62
###begin article-title 63
Site-directed mutagenesis using overlap extension PCR
###end article-title 63
###begin article-title 64
###xml 15 20 <span type="species:ncbi:9606">human</span>
Stimulation of human 8-oxoguanine-DNA glycosylase by AP-endonuclease: potential coordination of the initial steps in base excision repair
###end article-title 64
###begin article-title 65
Genetic and epigenetic modification of mismatch repair genes hMSH2 and hMLH1 in sporadic breast cancer with microsatellite instability
###end article-title 65
###begin article-title 66
Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA
###end article-title 66
###begin article-title 67
Structural and mechanistic studies on repair of 8-oxoguanine in mammalian cells
###end article-title 67
###begin article-title 68
Structural basis for the excision repair of alkylation-damaged DNA
###end article-title 68
###begin article-title 69
###xml 13 18 <span type="species:ncbi:4932">yeast</span>
Cloning of a yeast 8-oxoguanine DNA glycosylase reveals the existence of a base-excision DNA-repair protein superfamily
###end article-title 69
###begin article-title 70
###xml 135 139 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Age-related and tissue-specific accumulation of oxidative DNA base damage in 7,8-dihydro-8-oxoguanine-DNA glycosylase (Ogg1) deficient mice
###end article-title 70
###begin article-title 71
The discovery of a new family of mammalian enzymes for repair of oxidatively damaged DNA, and its physiological implications
###end article-title 71
###begin title 72
Figures and Tables
###end title 72
###begin p 73
###xml 70 73 70 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">796</sub>
###xml 75 78 75 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">797</sub>
###xml 80 83 80 83 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">798</sub>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
Diagram of PCR-based site-directed mutagenesis. Deletion of a C from C796 C797 C798 in OGG1 is shown as an example.
###end p 73
###begin p 74
###xml 220 222 219 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
###xml 121 129 <span type="species:ncbi:9606">patients</span>
###xml 324 332 <span type="species:ncbi:9606">patients</span>
The 8-oxoG glycosylase activity of nuclear extracts derived from brain of AD patients. Nuclear extracts (40 mug) from AD patients (AD1, AD2 and AD3) or age-matched controls (C1, C2 and C3) were incubated with 50 fmol of 32P-labeled 36-mer duplex containing a centrally located 8-oxoG residue. 8-oxoG cleavage activity in AD patients, except AD1, was lower than that in age-matched controls.
###end p 74
###begin p 75
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OGG1</italic>
###xml 46 47 46 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 338 339 338 339 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 342 345 342 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">796</sub>
###xml 465 466 465 466 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 35 43 <span type="species:ncbi:9606">patients</span>
###xml 69 77 <span type="species:ncbi:9606">patients</span>
###xml 401 409 <span type="species:ncbi:9606">patients</span>
###xml 495 498 <span type="species:ncbi:9606">AD4</span>
###xml 503 506 <span type="species:ncbi:9606">AD5</span>
Mutations of OGG1 identified in AD patients. (A) SSCP analysis of AD patients and age-matched controls. Whereas, samples with higher levels of 8-oxoG cleavage activity (AD1 and C3) exhibited two specific SSCP products (bands 1 and 4), samples with lower levels of 8-oxoG cleavage activity showed two additional products (bands 2 and 3). (B) C796 deletion in AD2 and AD3. The indicated SSCP bands from patients or controls were eluted, PCR-amplified and sequenced. (C) Base-base substitutions in AD4 and AD5. Arrows point to the altered nucleotides.
###end p 75
###begin p 76
###xml 48 49 48 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 105 106 105 106 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 394 395 394 395 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 360 367 <span type="species:ncbi:9606">patient</span>
Locations of the identified mutations in OGG1. (A) Partial protein and DNA sequences of wild-type OGG1. (B) Partial protein and DNA sequences of OGG1-59aa. Mutation site and original stop codon are highlighted. Recognition sequence of the restriction endonuclease BspMI is also highlighted, which was used to clone part of the exon 7 and 3'-UTR sequences from patient AD2 into pET28d plasmid. (C) Partial DNA and peptide sequences of mutants A53T and A288V. Important functional domains (modified from ) of OGG1 are also shown.
###end p 76
###begin p 77
###xml 102 110 102 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 150 151 150 151 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 237 238 237 238 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 400 401 394 395 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
OGG1-59aa has no glycosylase activity. 8-OxoG glycosylase activity was determined as described in the Figure 2 legends, but using purified proteins. (A) SDS-PAGE of purified recombinant wild-type and mutant OGG1 proteins, as indicated. (B) 8-oxoG glycosylase activity of wild-type OGG1 (W) and OGG1-59aa (M) using the indicated amount of proteins. Reactions were incubated at 37degreesC for 30 min. (C) Time course of 8-oxoG glycosylase activity assays of OGG1 (W) and OGG1-59aa (M). Each reaction contained 1.25 fmol of the indicated proteins.
###end p 77
###begin p 78
###xml 321 322 314 315 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 376 377 369 370 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 432 433 425 426 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 601 602 594 595 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 641 642 634 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 642 643 635 636 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
Reduced glycosylase activity in OGG1(A53T) and OGG1(A288V). Unless otherwise mentioned, 8-oxoG glycosylase activity was assayed in a 20-mul reaction containing 25 fmol of wild-type (W) or mutant (M) OGG1 and 50 fmol of oligonucleotide duplexes containing a single 8-oxoG. Reactions were incubated at 37degreesC for 1 h. (A) Time course of glycosylase activity of OGG1(A53T). (B) Time course of glycosylase activity of OGG1(A288)V. (C) Comparison of glycosylase activities among various OGG1 proteins. Each point represents the average value of three independent experiments, and error bars show SDs. (D) OGG1(A53T) and OGG1(A288V) possess a Km that is higher than that of OGG1. Reactions were assembled similarly as described in panels A and B, but incubated at 37degreesC for 30 min and in the presence of increasing DNA concentrations as indicated.
###end p 78
###begin p 79
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 69 70 69 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF1"><sup>a</sup></xref>
###xml 27 35 <span type="species:ncbi:9606">patients</span>
8-OxoG lesion levels in AD patients with and without OGG1 alterationsa
###end p 79
###begin p 80
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 36 37 36 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 44 45 44 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
aData were adapted from References (3) and (6) with permission.
###end p 80

